fbpx

< Back to Thought Leadership

New Requirements by Humana for 340B Participants

Attention 340B covered entities participating with Humana – Managed Care Medicare: Effective January 1, 2019, Humana requires that a “JG,” “TB,” or another relevant modifier be added to claims involving 340B eligible outpatient drugs under the Medicare Outpatient Prospective Payment System (OPPS) with status indicator “K.” If a claim does not include the proper modifier alerting Humana to the use of 340B drugs, Humana will automatically reduce the reimbursement rate to the average sales price (ASP) minus 22.5%.

This change by Humana resembles the January 1, 2018 decision by the Centers for Medicare and Medicaid Services (CMS) to reduce the Medicare allowed reimbursement rate for 340B purchased drugs from ASP plus 6 percent to ASP minus 22.5 percent. CMS simultaneously increased the conversion factor for all OPPS non-drug items and services by approximately 3.2%.

It may be prudent to reach out to Humana for clarity on this issue. A recent federal court ruling in Washington reversed the enormous cuts to the Medicare outpatient drug payments implemented by CMS. A federal judge ruled in late December 2018 that CMS and HHS exceeded their authority by cutting drug reimbursement by approximately 28.5 percent. While this ruling appears to be a win for the hospitals affected by the payments cuts, it is not certain how this issue will be settled. Additionally, there has been no guidance by Humana as to how this ruling affects its position.

We will continue to monitor the situation and update clients as more information becomes available. If you have any questions, please contact one of our 340B Apexus Certified Experts:

Bill Rees, Director
brees@blueandco.com
317-713-7942

David Layne, Manager
dlayne@blueandco.com
606-922-3796

Jason Prokopik, Pharmacy Manager
jprokopik@blueandco.com
317-713-7916

 

Click here to learn more about our 340B services.

Upcoming Changes to Your ERISA Plan Audits

Upcoming Changes to Your ERISA Plan Audits

Overview of SAS No. 136 On July 10, 2019, the Auditing Standards Board (ASB) of the American Institute of Certified Public Accountants (AICPA) issued Statement on Auditing Standards No. 136, Forming an Opinion and Reporting on Financial Statements of Employee Benefit Plans Subject to ERISA (EBP SAS) for financial statement audits of employee benefit plans […]

Learn More
CMS Final Rule under PPS for SNFs for FY 2020

CMS Final Rule under PPS for SNFs for FY 2020

CMS issued a proposed rule on July 30, 2019, with updates to the Patient-Driven Payment Model (PDPM), Quality Reporting Program (QRP), and the Value Based Purchasing Program  (VBP) for fiscal year 2020 ( beginning on 10/1/19 and ending on 9/30/20). See here for the final rule. The final rule was published in its official form […]

Learn More
Revenue Recognition (ASC 606) for Healthcare Entities

Revenue Recognition (ASC 606) for Healthcare Entities

Welcome to our video series on the new revenue recognition standard. This video, Revenue Recognition (ASC 606) for Healthcare Entities, highlights the key implementation considerations related to revenue recognition under Topic 606 for Healthcare organizations. If you haven’t already viewed the video, A Conversation on Revenue Cycle (ASC 606), we recommend doing so to get […]

Learn More